Medytox Secures NMPA Approval for NEURAMIS Dermal Filler in China
Medytox has received NMPA approval for its NEURAMIS hyaluronic acid dermal filler, opening the Chinese aesthetic medicine market to the Korean manufacturer.
Topic
Topic
Medytox has received NMPA approval for its NEURAMIS hyaluronic acid dermal filler, opening the Chinese aesthetic medicine market to the Korean manufacturer.
Medytox has secured Chinese regulatory approval for its NEURAMIS hyaluronic acid filler, gaining entry to one of the world's larg…